title: [Injection treatment with hyaluronic acid].
abstract: This article presents the spectrum of indications for the use of hyaluronic acid (HA) based on the recommendations of the European League Against Rheumatism (EULAR), the American College of Rheumatology (ACR), the Osteoarthritis Research Society International (OARSI), the International Institute for Health and Clinical Excellence (NICE) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) taking the reality of patient care in Europe into account.
authors.affiliation: Klinik für Orthopädie, Unfallchirugie und Sportmedizin, Johanna Etienne Krankenhaus, Am Hasenberg 46, 40416, Neuss, Deutschland. J.Jerosch@ak-neuss.de.
authors.forename: J
authors.initials: J
authors.lastname: Jerosch
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000592:standards; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000592:standards; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000592:standards; D005060:Europe; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage* / Q000592:standards*; D007270:Injections, Intra-Articular / Q000379:methods / Q000592:standards; D015552:Injections, Intralesional / Q000379:methods / Q000592:standards; D017410:Practice Guidelines as Topic; D012216:Rheumatic Diseases / Q000175:diagnosis / Q000188:drug therapy*; D012219:Rheumatology / Q000592:standards*; D014481:United States; D055675:Viscosupplements / Q000008:administration & dosage / Q000592:standards
chemical_list: D000276:Adjuvants, Immunologic; D018501:Antirheumatic Agents; D055675:Viscosupplements; D006820:Hyaluronic Acid
keywords: Arthritis; Indications; Management; Recommendations; Treatment